Search Within

Maria Elena Rodriguez Garcia-rendueles

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (5)
  2. Meeting Abstract (1)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (6)
  2. Department of Medicine (6)
  3. Division of Subspecialty Medicine (6)
  4. Endocrinology (6)
  5. GSK Faculty (6)
  6. Human Oncology and Pathogenesis Program (6)

More Groups

People
  1. James Fagin (6)
  2. Jeffrey Knauf (5)
  3. Ronald Ghossein (3)
  4. Adriana Heguy (2)
  5. Agnes Viale (2)
  6. Brian Untch (2)

More People

Years
  1. 2022 (1)
  2. 2019 (1)
  3. 2018 (1)
  4. 2015 (2)
  5. 2013 (1)
Publications
  1. Cancer Research (2)
  2. Cancer Discovery (1)
  3. Clinical Cancer Research (1)
  4. Journal of Clinical Investigation (1)
  5. Molecular Cancer (1)
Publishers
  1. American Association for Cancer Research (4)
  2. American Society for Clinical Investigation (1)
  3. Biomed Central Ltd (1)

Results (6)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Yap governs a lineage-specific neuregulin1 pathway-driven adaptive resistance to RAF kinase inhibitors
    Journal Article

    Garcia-Rendueles, M. E. R.; Krishnamoorthy, G.; Saqcena, M.; AcunĖƒa-Ruiz, A.; Revilla, G.; de Stanchina, E.; Knauf, J. A.; Lester, R.; Xu, B.; Ghossein, R. A.; more...
    Molecular Cancer (2022)

    Fulltext@MSK | Save
  • Comprehensive genetic characterization of human thyroid cancer cell lines: A validated panel for preclinical studies
    Journal Article

    Landa, I.; Pozdeyev, N.; Korch, C.; Marlow, L. A.; Smallridge, R. C.; Copland, J. A.; Henderson, Y. C.; Lai, S. Y.; Clayman, G. L.; Onoda, N.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Tipifarnib inhibits HRAS-driven dedifferentiated thyroid cancers
    Journal Article

    Untch, B. R.; Dos Anjos, V.; Garcia-Rendueles, M. E. R.; Knauf, J. A.; Krishnamoorthy, G. P.; Saqcena, M.; Bhanot, U. K.; Socci, N. D.; Ho, A. L.; Ghossein, R.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Altiratinib is a potent inhibitor of TRK kinases and is efficacious in TRK-fusion driven cancer models
    Meeting Abstract

    Smith, B. D.; Leary, C. B.; Turner, B. A.; Kaufman, M. D.; Wise, S. C.; Garcia-Rendueles, M. E. R.; Fagin, J. A.; Flynn, D. L.
    Cancer Research (2015)

    Fulltext@MSK | Save
  • NF2 loss promotes oncogenic RAS-induced thyroid cancers via YAP-dependent transactivation of RAS proteins and sensitizes them to MEK inhibition
    Journal Article

    Garcia-Rendueles, M. E. R.; Ricarte-Filho, J. C.; Untch, B. R.; Landa, I.; Knauf, J. A.; Voza, F.; Smith, V. E.; Ganly, I.; Taylor, B. S.; Persaud, Y.; more...
    Cancer Discovery (2015)

    Fulltext@MSK | Save
  • Identification of kinase fusion oncogenes in post-Chernobyl radiation-induced thyroid cancers
    Journal Article

    Ricarte-Filho, J. C.; Li, S.; Garcia-Rendueles, M. E. R.; Montero-Conde, C.; Voza, F.; Knauf, J. A.; Heguy, A.; Viale, A.; Bogdanova, T.; Thomas, G. A.; more...
    Journal of Clinical Investigation (2013)

    Fulltext@MSK | Save